MoneyWorks4Me

Rubra Medicaments informs about closure of trading window

03 Jan 2022 Evaluate

Rubra Medicaments has informed that pursuant to the Company's Securities Dealing Code, the Trading Window for dealing in the Company's Equity Shares will remain closed from Saturday, January 1, 2022 for all Designated Employees of the Company. The closure is in connection with the declaration of financial results of the Company for the quarter ending December 31, 2021.

The above information is a part of company’s filings submitted to BSE.

Peers